Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
Condition(s):Glioblastoma; Recurrent Glioblastoma; GBM; Newly Diagnosed GlioblastomaLast Updated:March 15, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Glioblastoma; Recurrent Glioblastoma; GBM; Newly Diagnosed GlioblastomaLast Updated:March 15, 2024Active, not recruiting
Condition(s):Long COVID; Post COVID Condition; Post Acute Sequelae of COVID-19Last Updated:October 2, 2023Recruiting
Condition(s):AnesthesiaLast Updated:June 23, 2023Completed
Condition(s):Cardiac Output, Low; Cardiac Output, High; Perfusion; ComplicationsLast Updated:October 19, 2022Recruiting
Condition(s):Shoulder Arthropathy; Shoulder PainLast Updated:January 12, 2024Recruiting
Condition(s):CRS; Polyp, NasalLast Updated:July 26, 2022Recruiting
Condition(s):SialorrheaLast Updated:April 16, 2014Completed
Condition(s):Primary Aldosteronism; Adrenal Cushing Syndrome; Pheochromocytoma; Endocrine NeoplasiaLast Updated:September 22, 2023Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:August 5, 2022Completed
Condition(s):Shoulder Rotator Cuff TendinitisLast Updated:June 30, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.